Clinical Trial Update: AnticoaguLation ONE Year After Ablation of Atrial Fibrillation in Patients With Atrial Fibrillation (ALONE AF Study) [Phase 4]

View source ↗

Summary

Phase 4 trial update for evaluating anticoagulation one year after atrial fibrillation ablation in patients at moderate to high stroke risk.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Anticoagulant

Snippet

Sponsor: Yonsei University | Conditions: Atrial Fibrillation Patients With Moderate or High Stroke Risk Who Had Undergone Catheter Ablation of Atrial Fibrillation | Phase 4 | Status: RECRUITING